Association of Vascular Endothelial Growth Factor (VEGF) serum levels And Ankylosing Spondylitis in Egyptian patients

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202210522771809

Enrollment

Registered

2022-10-27

Start date

2022-11-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ankylosing spondylitis

Interventions

evaluate the serum VEGF levels in Egyptian patients with AS

evaluate the serum VEGF levels in Egyptian

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Adult AS(ankylosing spondylitis ) patients 20-60 years old met the modified New York criteria for AS.

Exclusion criteria

Exclusion criteria: Patients with any associated rheumatic diseases. - patients with cancers. - Diabetic patients

Design outcomes

Primary

Measure	Time frame
evaluate the serum VEGF levels in Egyptian patients with AS	—

Secondary

Measure	Time frame
serum VEGF levels in Egyptian patients with AS, and its relation to disease-related parameters including radiographic outcomes.	—

Countries

Egypt

Contacts

Public ContactHossam Labib

Lecturer

dr.sam789@yahoo.com01002058687

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026